BSG and urinary bladder cancer: CD147-associated exosomes have been identified in malignant ascites from ovarian cancer patients [96] and in bladder cancer [97], and recent evidence suggests that CD147-containing extracellular vesicles can be extracted from cancer patient sera as a biomarker to monitor response to therapy [98].